CA
NZ
UK
AU
IND
US
Anterix Inc. filed a Form 8-K on September 18, 2026, disclosing that its Board of Directors authorized a new share repurchase program of up to $250,000,000 in common stock, effective September 22, 2026, and running through September 22, 2029.
The Kroger Co. filed its Form 10-Q for the quarterly period ended August 15, 2026, with the Securities and Exchange Commission on September 18, 2026, covering second-quarter and first-half financial results for the supermarket and grocery retailer.
First Carolina Financial Services, Inc. (NYSE:FCBM) filed a Form 8-K on September 18, 2026, disclosing the planned retirement of its Chief Financial Officer and Chief Risk Officer, a completed subordinated notes redemption, and preliminary net interest margin estimates for July through September 2026.
Third Coast Bancshares, Inc. filed a current report on September 18, 2026, disclosing that board member Jeffrey A. Wilkinson resigned from the company's Board of Directors effective September 17, 2026.
Farmers National Banc Corp. filed a Form 8-K on September 18, 2026, disclosing that its Senior Executive Vice President and Chief Operating Officer, Myke Matuszak, will depart the company effective October 15, 2026.
Concentrix Corporation filed an 8-K on September 18, 2026, disclosing that Cormac Twomey, Executive Vice President, Customer Success, will step down from his role effective December 31, 2026, following an agreement reached on September 15, 2026.
Lennox International Inc. filed a current report on Form 8-K on September 18, 2026, disclosing that its Compensation and Human Resources Committee approved a new form of Long-Term Incentive Award Agreement for U.S. employees at the Vice President level and above, effective September 16, …
Civista Bancshares, Inc. filed an 8-K on September 18, 2026, under Item 7.01 Regulation FD Disclosure, announcing the company's participation at the Stephens 16th Annual Bank Forum on September 23-24, 2026, in Little Rock, Arkansas.
A statement of changes in beneficial ownership filed on September 18, 2026, disclosed that Thomas Fuchs, a director of GeneDx Holdings Corp., acquired 1,146 shares of Class A Common Stock through the settlement of restricted stock units on September 17, 2026.
GeneDx Holdings Corp. Chief Financial Officer Kevin Feeley filed a Form 4 on September 18, 2026, reporting the vesting of restricted stock units and a related "sell to cover" transaction in Class A Common Stock on September 16, 2026.
Please wait processing your request...